« BACK  |  PRINT

RS

MEMBER DIARY

The Co-payment Conundrum

From the diaries by Kevin.

Part of the health care plan problem in the U.S. is that it does not use the free enterprise system as well as it could to contain costs. Some reasons for these problems are federal and state government mandates and regulations. Outside of government regulations however, there is one health care policy that underutilized the power of capitalism to contain costs. This is the co-payment system for purchasing drugs.

If you have a health care plan like I do (and as far as I understand the vast majority of plans work this way) then if you need a prescription drug you can go to any pharmacy and only have to pay one amount no matter what drug it is. Your health care plan covers the rest. For example, let’s say you have high cholesterol so your doctor prescribes Lipitor. Without drug coverage, you would pay about $100 for 30 tablets of 10mg each. With coverage you pay $10 and your health care plan picks up the rest. If you have mental health problems, your doctor might proscribe Trazodone. Without coverage 30 tablets of 50mg would range in cost from about $11 to almost $25. With coverage you would still only pay $10 no matter where you buy it.

As a consumer this sounds like a great bargain. No matter what health problem I might have, my doctor can proscribe something, and I only have to pay a set amount. There is no hunting around on price so I can just pick it up at the most convenient drug store closest to my home or on the way to work.

From a health care coverage plan, however, it sounds like a terrible way to do business. There is no incentive for the purchaser to control costs. There can be tremendous store-to-store variations in what stores charge. You can investigate some of them (in Michigan at least) through the state government website. I do not understand why health care plans can’t use a similar method to enlist their customers as a force to control drug costs. It is not that difficult to set up a website and have pharmacies report their prices to the health care company. It should not be difficult for customers to use such a website to compare drug prices. For those who are not web savvy, they could also have an automated phone system.

They could incentivize the co-payment with a fairly simple formula. The regular co-payment would apply to the average price reported for a drug. Anything cheaper would reduce the co-payment by a percentage. Anything more expensive would increase it. For example, for the Trazodone let’s say the average cost is $18 so your co-payment for it would be $10 at that price. If you can find a store selling it for $11, your co-payment would be $6. If you are lazy and buy it at a store charging $25 then your co-payment would be $14. Or for another example, take Geodon which costs from $386 to $475. At the average of $430, the co-payment is $10. At the cheapest price of $386 it is $9. At the most expensive it is $11. (Of course, the formula could be adjusted for greater incentive.)

This should be a win-win situation. You pay less and your customer pays less. This would also benefit even those without coverage because it would drive down drug prices for everyone. This is the way a free market should work. With a third-party-payer system like we have in the U.S., co-payment incentives like this should be appealing. If employees shy away from the small additional hassle of competitive pricing the employer should see a benefit from cost savings. It should be a triple-win – for the health care provider, the employer, and the employee.

Why isn’t this system of drug pricing being used? Is it available somewhere but I just haven’t heard about it? Are there federal or state regulations against it? (If there are they should be repealed.) Granted this issue is not the only problem with our health care system. It is probably not even in the top five. However it should be something easily implemented and shouldn’t need political pressure. It might even be a smart idea to implement in our current government systems of Medicare and Medicaid.

Get Alerts

COMMENTS

  • mom2oneson

    but why don’t more insurance companies order from outside the US pharamcies? I use a Candadian pharamcy and it’s so much cheaper. I wish I had known about it before I wouldn’t have gone without in the past or stressed out on how much I spent on medicine. It’s so convenient they deliver it through the postal service. This doesn’t work for everything but for people with chronic conditions it’s a great service.

    I think companies should be able to price however they want, but some things I don’t get, why do they the same or just a little more for another pill at double the dose? Why does 20 mg and 40 mg of one drug cost the same or close.
    It’s like that even for pet care stuff. I buy flea medicine for an XXL dog and dose it into 8 doses for my cats.

    • Kyle-MI

      Canada sets government price controls on their drugs that have very little to do with the cost of research or producing them. Re-importation laws are just a way of hiding price controls. We get government controlled prices, but it isn’t even our government and we don’t even get to vote for the people setting the price controls. It is the worst of all worlds.

  • Tbone

    “Why does 20 mg and 40 mg of one drug cost the same or close.”

    It’s the amortization of research, marketing and distribution that account for the vast majority of the cost in each pill.

    • 6eorge Jetson

      nt

      • Kyle-MI

        The numbers I heard are that it takes, on average, about 10 years from filing the patent to getting final FDA approval. Average costs for everything needed for FDA approval is about $500 million. Drug patents are good for 17 years which means that you have 7 years left to recover those costs. This is just for the drugs that survive approval. You also have to cover the cost of drugs that flunk out, although the sooner they flunk the less FDA approval costs are.

  • fwszolek

    First, I don’t know anybody who has a flat $10 deductible for every kind of prescription drug anymore. Most drug plans already employ a sliding scale that might start at $10 for a generic drug, while scaling up considerably higher for a brand name drug that’s still under patent, such as Lipitor, which you used as an example. The co-pay on something like that might be $40 or more — if the insurance company will even choose to pay for it.

    Sometimes this is just bad benefit design on the part of the insurance company. For a drug like Lipitor, which is designed to lower cholesterol thereby preventing heart attacks and strokes, the proper co-pay might be zero. Give the stuff away if it keeps people from extremely expensive medical events like strokes. But so-called “Health Maintenance Organizations” aren’t always thinking about health maintenance; they just want to save a buck this month and not worry about what might happen down the road.

    When voters complain about the rising cost of health care, skyrocketing co-pays are what they’re talking about. Most voters aren’t paying insurance premiums or directly paying docs and hospitals. They’re paying the co-pays. And they remember when a trip to the drug store cost $20, and now it costs hundreds.

    There is a very good reason for a lot of people not to shop around from drug store to drug store if they take more than one or two meds or they see more than one doc. It’s the drug store that best monitors drug interactions to make sure one doc doesn’t give you one thing, while another doc gives you something that cancels it out or has a huge side effect. It isn’t smart to buy your meds in different drug stores all over town.

    • GCBWI

      on what they’ll pay. My coverage has three categories. Copays in the lower two categories apply to an annual maximum. Copays in the highest category don’t apply to the maximum.

      The lowest category is mostly generic drugs, so there is an incentive to choose them over name-brand versions of the same drug.

    • The_Rebel

      n/t

      • Herodotus

        $0.00

  • http://andrightlyso.com/ civil_truth

    Right now, most insurance companies use such a schema for deciding on what payment they will make to providers – and their methodology is shrouded in secrecy. Effrorts to make this transparent would be hampered by claims that the methodology would be a “commercial secret”.

    Similarly, given the number of drugs in use, an attempt to decide upon the “average price” of a drug would be extremely complex and would be extremely sensitive to methodology. How much time and effort would it take to obtains this information – and how often would this be updated? What would be your data source? And how many geographic areas would the country be divided into to determine a true local cost? The amount of information and programming would be a staggering cost and prone to all sorts of error, which a insurance customer would be unable to challenge – since the methodology would be secret like existing methods for assessing prevailing professional costs.

    The point of the co-payment system is to provde some level of patient investment. The benefit of moving from zero to some level of copayment is quite substantial in terms of limiting frivolous usages that run up costs to the insurance which the customer views as cost-free to them. Further fine-tuning the system as you suggest would almost certainly involve far more cost and potential for abuse and fraud than any savings thereby gained.

  • Kyle-MI

    All the prescription drug companies ship their products to anywhere in the U.S. Also, anyone can potentially mail order from anywhere in the U.S. For drugs, I would average over the entire U.S. Base the average on what people in your plan paid for drugs over the past week or month. At worst, for rarely used drugs, you can just go back to the single co-payment system. At least for widely used drugs you have incentives.

    The idea is to get your customers to do the leg work for you. Incentivize them to shop around. If you are trying to control everything through complicated formulas then you are not using the market.

    I wonder if the problem is that people running the health care plans think they are so smart that they work more efficiently than the market.

  • http://andrightlyso.com/ civil_truth

    …especially when you’re talking about only a few dollars benefit. There’s the time cost of price shopping, travel costs, loyalties, etc. that’s going to swamp a few dollars drug cost. So I don’t see how you’re going to get enough consumers to change seller behavior at the retail level.

    I suspect instead what is going on is that the insurance companies negotiate preferred pricing with retailers (especially large retailers) – and incentivize their customers to use the retailers. This is a lot cheaper for the insurance firm than the complex plans you’ve come up with that would be an administrative nightmare to carry out.

  • Herodotus

    Most of the medical insurance plans I have looked at (I refuse to participate in any of them) have co-pay tiers. For example, a generic drug that was ordered/refilled from a selected list of online pharmacies has a $10.00 co-pay. A generic drug ordered/refilled at a brick and mortar pharmacy has a $20.00 co-pay. While non-generic drugs that are ordered/refilled have a $30.00 co-pay.

  • Herodotus

    Just go to Wal-Mart for the $4 drugs. Most of the doctors that I have seen in recent years will try to prescribe from the Wal-Mart lists if possible.

  • Kyle-MI

    It can be done with only a little work from the customer and the pharmacy. The pharmacies would report their prices (via the website). If they don’t report then they don’t get the health care plan business.

    I don’t think there is preferred pricing. At least with my plan, there are no restrictions on pharmacies. If there was preferred pricing, I would expect the plans to incentivize toward those pharmacies.

  • Vaughn Harold

    plan this year, and trust me there is major variations on pricing for the same drug at different pharmicies through the same insurance carrier, and I would bet that certain health insurance companies get better deals than others at with certain pharmacy chains.

    I will add that the High Deductible plan does exactly what you are stating, it creates competition because I now know exactly how much I’m paying for healthcare services. My family has already made adjustments in how we do things as a result.

    The co-payment system is flawed as you’ve stated because the consumer has no ideal what the actual healthcare cost is. All they know is I can afford $30 to go to the doctor, no matter what that doctor orders. This in turn allows the doctors to cover their bottoms by ordering very expensive tests that aren’t really needed.

  • red4ever

    This is from a chat on WAPO today about the trauma response to the Metro train crash yesterday:

    Keshena, Wisc.: How will the proposed health care reforms affect your ability to respond to these types of situations?

    Janis Orlowski: Hi Dad

    It is very expensive to maintain at an “alert” status a level one trauma center. This requires nurses, doctors on site, ORs, blood products, experienced trauma and neurosurgeons and the expertise to respond immediately. As the president and Congress look to reform health care they will need to determine how to pay for primary care needs and how to maintain these centers of excellence in emergency response. The American people must also ask how much they are willing to pay for this level of care.

    _______________________

    Wanna bet that with Obamacare, trauma response training goes down resulting in greater loss of life?

  • 6eorge Jetson

  • douglast

    insurers pay according to preset contract rates, not pharmacy retail prices. Thus, for insured patients, all the pharmacies in your example will get paid (roughly) the same amount, regardless of what their asking price is.

  • DONTREADONME

    I am just curious, I always wonder how someone can just comment out of the blue on an issue like this. This is a serious question.

  • SteveLA

    DONTREADONME

    I have no clue why douglast has one one comment over the past year, but I actually think he’s right on the way insurance works with pharmacy’s.

    As to the rest of the premise of this suggestion, when I am sick, the absolute last thing I want to do is go around and comparison shop for my prescription needed to get well. I just went through this with a bum knee, gave the Doc the name of the pharmacy to the house, Dr. electronically sent the prescription which was ready to pickup by the time I got there. Done!

    f I have something that is going to take long term medications, my insurance plan has a mail order option at deep discounts.

    This is a really terribly bad idea right up there with taxing my health care insurance to pay for those who have none. It’s government meddling in something that they have no business in…PERIOD.

  • DONTREADONME

    I thought the “this is a serious question” meant I was more curious about how one come’s around and comments one time. I do not dispute any point he made. My insurance plan has multiple tier of coverage for prescriptions, name brand require a copay $35, generics $10.00, some drugs requie me to cover 30% and others are not covered at all. So my prescription copay system is a little more market oriented with varying copays.

    My insurance carrier recommends that we use their mail pharmacy which means I can get 90 day supply for $10 dollars versus the equivalent 30 day supply generic for $10. IMO the insurance company has made deals with the drug supplier allowing them to reduce their cost (overhead) by shipping orders via mail. Once again, I think we are moving on something here, but it appears insurance companies are slowly moving in that direction.

  • douglast

    I’ve been an on and off reader of RS for a few years at least. yesterday, I saw this post, and saw an opportunity to correct some factual misconceptions.

    I worked over 13 years in the retail and mail order pharamcy industry, both for large regional drug store chains, as well as for independent mail order operations. I’ve been involved at both the corporate and local levels in purchasing, pricing, and insurance contracting, so I know the system pretty well.